The Pharma Data & AI Security Playbook
A Blueprint for Securing Sensitive Data

Pharma organizations are adopting AI fast across drug discovery, R&D, and clinical studies, but their sensitive data is spread across multicloud platforms, SaaS apps, and LLM workflows. That fragmentation creates visibility gaps and new security risks that legacy tools can’t handle.

You will learn how pharma security leaders can reduce data chaos, safely accelerate AI adoption, cut compliance effort through automation, and operationalize data and AI security using an enterprise-grade DSPM approach.

DSPM creates unified visibility into sensitive data, its context, and how it’s used. This enables pharma teams to prioritize real risks, automate controls, and confidently unlock high-value AI use cases without slowing innovation.

DSPM discovers and classifies sensitive research, clinical, and patient data, maps how it flows into AI models, and enforces least-privilege access, masking/redaction, and risk correlation. That ensures AI systems train and operate only on governed, compliant data.

Yes. By automating discovery, control mapping, evidence collection, and continuous monitoring across environments. Instead of manual spreadsheets and periodic audits, compliance becomes always-on and audit-ready.

CISOs, security architects, privacy/compliance leaders, and data/AI governance teams in pharma and biopharma who need to protect sensitive data while scaling AI responsibly.